openPR Logo
Press release

2026 Japan Oncology Drugs Market 2020 Analyzed by Top 5 Key Players by Size, revenue and Forecasts

02-07-2020 01:46 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Japan Oncology Drugs Market

Japan Oncology Drugs Market

"Japan Oncology Drugs Market by Drug Class Type, and Indication: Opportunity Analysis and Industry Forecast, 2019-2026," the Japan oncology drugs market accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5642

Cancerous cells are formed when the normal cells present in the body grow at an uncontrolled rate. This abnormal growth leads to the formation of a tumor which can spread to other localized tissues. Moreover, cancer has different stages based on the growth of tumor. Metastasis is the final stage of the disease, which is marked by the invasion of tumor in other parts of the body. The management of cancer in patients requires the use of different drugs such as hormonal therapy, immunotherapy, targeted therapy, and others.

Factors such as rise in incidence of cancer in Japan, increase in healthcare expenditure and surge in research related to new drug discovery for cancer treatment in the region are the major factors that boost the growth of Japan oncology drugs market. Furthermore, surge in geriatric population also contributes to the growth of the market as the elderly are more prone to certain cancer such as prostate cancer. Moreover, surge in awareness related to early diagnosis of cancer leading to rise in demand of oncology drugs for treatment is another factor that fuels the growth of the market in Japan. In addition, rise in number of pipeline products is expected to provide lucrative opportunities during the forecast period.

However, stringent approval process of oncology drugs in Japan hinders the growth of market
The Japan oncology drugs market is segmented on the basis of drug class type and indication. Based on drug class type, the market is divided into chemotherapy, targeted therapy, immunotherapy, hormonal therapy. By indication, it is categorized into blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, lung cancer, skin cancer, ovarian cancer, cervical cancer, kidney cancer and others.

For Full Report @ https://www.alliedmarketresearch.com/japan-oncology-drugs-market

Depending on drug class type, the targeted therapy segment occupied the largest share of Japan oncology drugs market in 2018. This is attributed to lesser side effects of the targeted therapy drugs as compared to other treatment options. Targeted therapies have the ability to kill only malignant cells thereby exhibiting better treatment outcomes which fuel the growth of market. In addition, higher efficacy and higher survival rates associated with the use of targeted therapy drugs are other reasons that fuel the growth of the market. Furthermore, immunotherapy segment is expected to show fastest growth during the forecast period. This is due to wide acceptance of immunotherapy drugs as an ideal treatment option for cancer.

Immunotherapy drugs are ideal treatment options as these drugs are potentially harmless to the other living cells of the body which makes them less toxic as compared to other modes of cancer therapies. Moreover, continuous efforts in R&D to design and develop new immunotherapeutic for the treatment of various cancer types serves as a key factor for market growth.
Based on indication, the prostate cancer segment occupied the largest share of market in 2018 owing to the presence of huge geriatric population. However, lung cancer segment is expected to show fastest growth during the forecast period attributed to technological developments in the field of cancer diagnostics and rise in the awareness related to the early diagnosis of cancer.

According to Onkar Sumant, Manager, Healthcare at Allied Market Research, "Surge in prevalence of cancer is anticipated to significantly drive the growth of the Japan oncology drugs market. Furthermore, rise in geriatric population, increase in healthcare expenditure, and upsurge in awareness related to early screening of cancer are the key factors that augment the market growth."

Key Findings of the Japan Oncology Drugs Market:
o Targeted therapy occupied approximately half share of the Japan oncology drugs market in 2018.
o The immunotherapy segment is anticipated to grow with the highest CAGR throughout the forecast period.
o The gastrointestinal cancer segment accounted for two-fifth share of the market in 2018.
o Lung cancer is anticipated to grow at the highest rate during the analysis period.

Related Reports:
Acute Ischemic Stroke Diagnosis and Treatment Market
https://www.alliedmarketresearch.com/acute-ischemic-stroke-diagnosis-and-treatment-market

Vascular Graft Devices Market
https://www.alliedmarketresearch.com/vascular-graft-devices-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2026 Japan Oncology Drugs Market 2020 Analyzed by Top 5 Key Players by Size, revenue and Forecasts here

News-ID: 1923642 • Views: 144

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Japan

Global Car Navigation ECU Market Outlook to 2023 – AW Software (Japan), Contin …
An automotive navigation system is part of the automobile controls or a third party add-on used to find direction in an automobile and the ECU is the core part control it. Car Navigation typically uses a satellite navigation device to get its position data which is then correlated to a position on a road. According to this study, over the next five years the Car Navigation ECU market will register a
Data Lines 2017 Global Market Key Players –Sharp(Japan), Sony(Japan), …
Data Lines Market 2017 The global Data Lines market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies
Agrochemicals Market in Japan
ReportsWorldwide has announced the addition of a new report title Japan: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports. The report “Japan: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG) in the report. A
Consumer Electronics in Japan
Summary Consumer electronics saw annual retail volume decline throughout the review period. This was linked to consumers’ economic uncertainty, population decline and an ongoing shift towards smartphones as an all-in-one device. Smartphones are increasingly used to go online, communicate, play media, capture images and read e-books, with many consumers thus ceasing to buy a wide range of consumer electronics. 2016 however saw the softest retail volume decline of the review period,
Overseas Trade into Japan
Action Storage Systems is actively seeking distributors overseas in an attempt to grow the business in these difficult economic times. In October this year they have set up a new distributor in Japan for the sale of their eXtreme Plastic Lockers®. Koyo specialise in the sale and manufacture of locker systems from their base in Nagano and were established in 1961. Koyo sell throughout Japan and employ fifty sales
Japan Boosts Stimulus
The Bank of Japan has eased monetary policy by expanding asset purchases in a bid to boost growth, and left interest rates unchanged at between zero and 0.1%. The Bank of Japan has eased monetary policy by expanding asset purchases as the yen's strength and slow progress by European leaders in solving the region's debt crisis cloud the outlook for the country's fragile economy. The Bank of Japan (BOJ) has expanded